Feasibility and Safety of the REVERT Technique for Single-Access Endovascular Treatment of Peripheral Artery Disease

Abstract

Purpose

Peripheral artery disease (PAD) is associated with increased mortality, limb loss, and disability, impacting over 230 million individuals globally. The REVERT technique, designed for single-access management of ipsilateral lower extremity PAD, may reduce complications related to multiple punctures. This study aims to evaluate the efficacy and safety of the REVERT technique in endovascular interventions.

Methods

This retrospective study reviewed 12 patients treated with the REVERT technique at our institution from January 2019 to October 2022. Patient demographics (age, gender, Rutherford classification) and procedural data (sheath sizes, puncture methods, hemostasis techniques) were collected. Complications were assessed based on the Society of Interventional Radiology standards.

Results

The mean age of the cohort was 72 years, with 75% male patients, and 58.3% presented with critical ischemia (Rutherford ≥4). No acute limb ischemia cases were observed, and the REVERT technique was successfully performed in all cases without major complications. One case of sheath kinking was resolved by replacing it with a kink-resistant sheath.

Conclusion

The REVERT technique appears to be a safe and effective method for single-stage endovascular treatment of ipsilateral or bilateral PAD, with minimal complications. Larger-scale studies are recommended to further validate these findings and optimize clinical applications.

Keywords

REVERT technique - endovascular intervention - single-access approach

Ethical Approval

This retrospective study protocol adhered to the principles outlined in the Declaration of Helsinki and received approval from the institutional review board under reference number 2022000604–1.

Informed Consent

Individual informed consent was routinely obtained from all patients for their procedures, but additional consent specific to the study was not required due to the retrospective nature of the research.

Availability of Data and Materials

The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Publikationsverlauf

Artikel online veröffentlicht:
26. März 2025

• References

• 1 Ray KK, Ference BA, Séverin T. et al. World Heart Federation Cholesterol Roadmap 2022. Glob Heart 2022; 17 (01) 75
• 2 Gerhard-Herman MD, Gornik HL, Barrett C. et al. 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: executive summary—a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017; 135 (12) e686-e725
• 3 Thukkani AK, Kinlay S. Endovascular intervention for peripheral artery disease. Circ Res 2015; 116 (09) 1599-1613
• 4 Kadoya Y, Zen K, Kato T. et al. Feasibility and safety of reverse catheterization technique of the superficial femoral artery in single-stage endovascular treatment of bilateral infrainguinal diseases. Vasc Endovascular Surg 2019; 53 (03) 206-211
• 5 Rajebi H, Rajebi MR. Optimizing common femoral artery access. Tech Vasc Interv Radiol 2015; 18 (02) 76-81
• 6 Irani F, Kumar S, Colyer Jr WR. Common femoral artery access techniques: a review. J Cardiovasc Med (Hagerstown) 2009; 10 (07) 517-522
• 7 Kinnaird TD, Stabile E, Mintz GS. et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 2003; 92 (08) 930-935
• 8 Khalilzadeh O, Baerlocher MO, Shyn PB. et al. Proposal of a new adverse event classification by the Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol 2017; 28 (10) 1432-1437.e3
• 9 Hartnell G. An improved reversal technique from retrograde to antegrade femoral artery cannulation. Cardiovasc Intervent Radiol 1998; 21 (06) 512-513
• 10 Miralles M, Candela E, Blanes E, Ribé L. Reverse retrograde approach: an alternative method for ipsilateral access to the superficial femoral artery. EJVES Short Rep 2016; 30: 7-9